Teva Agrees to Pay $225 Million to Settle U.S. Price-Fixing Charges
The generic drugmaker’s U.S. unit also must sell drug line for cholesterol treatment pravastatin.
The generic drugmaker’s U.S. unit also must sell drug line for cholesterol treatment pravastatin.